Share this article
Share this article
USD 936.4 million by 2028 according to a new study conducted by
Polaris Market Research. The market is anticipated to register a
CAGR of 7.5% From 2021 – 2028. A rise in the vulnerability of women diagnosed with cervical dysplasia and
growing awareness among people for investing more in getting regular check-ups for their health are the key factors driving the market growth. In addition to this, medical practitioners are also working to improve their functional systems to effectively manage the disease diagnosis and monitoring, which in turn boosting the overall development of the market. A rise in the number of awareness programs and initiatives for spreading the importance of the early diagnosis of the disease is further complements the growth of the market.
is projected to reach USD 5.31 billion by 2027 according to a new study conducted by Polaris Market Research the market is anticipated to register a
CAGR of 5.1% from 2020 to 2027. An increasingly aging population has gradually resulted in a rise of cases of lewy body dementia, which is one of the primary factors driving the growth of the global market. A higher number of dementia cases in developed countries are creating strong demand for effective drugs and leading manufacturers bringing new products tailored to cure the disease are expected to fuel significant demand for dementia treatment in the global market. An increased government effort to spread awareness regarding the treatment for lewy body dementia and the rising prevalence of brain-related disorders is foreseen to strengthen the market growth.
Share this article
Share this article
USD 23.67 billion by 2027 according to a new study conducted by
Polaris Market Research. The market is
anticipated to register a CAGR of 2.9%
From
2020 – 2027.
An increase in COVID-19 patients across the world and the need for rapid diagnostics are anticipated to drive the growth of the global market. Several countries are conducting testing for the diagnosis of COVID-19 and to isolate patients affected by the virus, helping to limit its spread is one of the key factors boosting the market growth. Rising awareness among physicians and patients regarding the crucial benefits of COVID-19 diagnostics is positively influencing the market. Increased fear among people for infectious virus coupled with healthcare professional s suggestions for early diagnostics to contain the risk of virus infection, boost the global COVID-19 diagnostics market. The rise in government initiatives and programs to encourage early diagnostic testing